Ai, Dashan
Chen, Yun
Liu, Qi
Deng, Jiaying
Zhang, Xiaofei
Zhang, Junhua
Chu, Li
Shen, Jingyi
Ma, Longfei
Zhang, Yawei
Chen, Haiquan
Miao, Longsheng
Zhao, Kuaile
Xiang, Jiaqing
Clinical trials referenced in this document:
Documents that mention this clinical trial
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
https://doi.org/10.1186/s13014-023-02211-w
Funding for this research was provided by:
National Key Research and Development Program of China (MOST-2016YFC1303200)
National Natural Science Foundation of China (21172043)
Article History
Received: 13 July 2022
Accepted: 20 January 2023
First Online: 7 February 2023
Declarations
:
: The protocol was approved by the Ethics Committee of Fudan University Shanghai Cancer Center. All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.